e-learning
resources
Milan 2017
Monday, 11.09.2017
Functional genomics knowledge in parenchymal and bronchial diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in lung fibroblast response to TGF-β and pulmonary fibrogenesis
B. Mari (Valbonne, France)
Source:
International Congress 2017 – Functional genomics knowledge in parenchymal and bronchial diseases
Session:
Functional genomics knowledge in parenchymal and bronchial diseases
Session type:
Oral Presentation
Number:
2908
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Mari (Valbonne, France). The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in lung fibroblast response to TGF-β and pulmonary fibrogenesis. 2908
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
MicroRNA-34a drives small airway fibroblast cellular senescence in COPD
Source: International Congress 2017 – New Mechanistic Findings in COPD
Year: 2017
Krüppel-like factor 4 (Klf4) is a novel regulator of neonatal lung fibroblast homeostasis and reduced in hyperoxia-induced lung injury
Source: International Congress 2018 – Molecular and cellular determinants of the developing lung
Year: 2018
Down regulation of human insulin-like growth factor in lung tissue of patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 574s
Year: 2007
Reactivation of developmental pathways in idiopathic pulmonary fibrosis: FGF9 and FGF18 modulate the phenotype of control and fibrotic human lung fibroblasts in vitro
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
The role of pathological angiogenesis in the pathogenesis of the chronic inflammatory lung diseases
Source: Annual Congress 2005 - Update on the role of angiogenesis in the pathogenesis and treatment of lung diseases
Year: 2005
c-Met expression induction in immune cells modulates pulmonary fibrosis progression
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020
The lung epithelial clock and its role in lung inflammation
Source: International Congress 2017 – The circadian molecular clock in respiratory diseases and associated interventions
Year: 2017
The role of epithelium-dependent fibroblast activation in pulmonary fibrosis
Source: Virtual Congress 2021 – Chinese programme 2021
Year: 2021
IL-11 promotes pulmonary vascular remodeling and lung fibrosis through the activation of endothelial to mesenchymal transition.
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020
Endothelin-1 induced connective tissue growth factor expression in human lung fibroblasts by ETAR-dependent JNK/AP-1 pathway
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
Cell specific gene transfer of hepatocyte growth factor reduces bleomycin-induced lung fibrosis by inhibition of partial EMT
Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon
Year: 2008
Decreased expression of FENDRR, a lung mesenchymal long non-coding RNA, regulates fibroblast phenotypes in IPF through NOX4.
Source: International Congress 2017 – Functional genomics knowledge in parenchymal and bronchial diseases
Year: 2017
The role of the COPD susceptibility gene FAM13A in barrier function and pro-inflammatory responses of human airway epithelial cells
Source: ERS Lung Science Conference 2020
Year: 2020
The role of the epigenetic regulator HMGN5 in COPD resulting from chronic lung injury
Source: ERS Lung Science Conference 2017
Year: 2017
Dickkopf proteins influence lung epithelial cell proliferation in idiopathic pulmonary fibrosis
Source: Eur Respir J 2011; 37: 79-87
Year: 2011
Haemophilus influenzae
(NTHi) up-regulates acute inflammation in human lung tissue and causes downregulation of transforming growth factor-beta (TGF-beta) – A possible role of NTHi in remodeling processes in human lung tissue
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010
Wnt-inducible protein (WISP-1) is a key regulator of alveolar epithelial cell hyperplasia in pulmonary fibrosis
Source: Eur Respir Rev 2006; 15: 180-181
Year: 2006
Wnt-inducible protein (WISP-1) is a key regulator of alveolar epithelial cell hyperplasia in pulmonary fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 147s
Year: 2006
Regulation of alternative macrophage activation by galectin-3; potential role in lung fibrosis
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
Toll like receptor 4 activation upregulates miR-181b attenuating pulmonary fibrosis via targeting TGFBR1
Source: International Congress 2015 – Latest news on miRNAs in pulmonary research
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept